Delivery Order SPE2DE22D0008-SPE2D626F4J6F
Award Date 4/30/26
Potential Completion Date 7/7/26
Potential Value $4.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency's Medical Supply Chain issued a $5,805 delivery order to Alba Bioscience, Inc. on March 13, 2026, for an Albacyte Antibody ID Panel (10-cell) with an ultimate completion date of May 15, 2026.</p> <p>Place of performance is Chicago, IL 60607. The order is firm fixed price with no set-aside designation.</p>
- <p>The Defense Logistics Agency Medical Supply Chain issued a $3,792 delivery order to Alba Bioscience, Inc. on April 30, 2026, for ALBACLONE anti-A immunohematology reagents, with an ultimate completion date of May 5, 2026.</p> <p>Place of performance is Chicago, IL. The order is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency's Medical Supply Chain issued a $6,943 delivery order to Alba Bioscience, Inc. on March 2, 2026, for ALBACLONE Anti-S monoclonal antibodies, with an ultimate completion date of March 5, 2026.</p> <p>Place of performance is Chicago, IL. Alba Bioscience specializes in immunohematology reagents and blood banking diagnostic materials for federal healthcare systems. The order is priced on a firm fixed price basis with no set-aside designation.</p>
- The Defense Logistics Agency's Medical Supply Chain issued a $1,156.60 delivery order to Alba Bioscience, Inc. on March 24, 2026, for ALBACLONE Anti-LEA monoclonal antibodies, with ultimate completion on March 27, 2026. Place of performance is Chicago, IL 60607. Alba Bioscience specializes in immunohematology reagents and blood banking diagnostic products for federal healthcare systems, including monoclonal antibodies targeting various blood group antigens, antibody identification and...
- The Defense Logistics Agency's Medical Supply Chain division issued a $3,269.00 delivery order to Alba Bioscience, Inc. on December 19, 2025, for an Albacyte Antibody ID Panel (16-cell) with an ultimate completion date of February 26, 2026. Place of performance is Chicago, IL. Alba Bioscience specializes in immunohematology reagents and diagnostic testing materials for federal healthcare systems, including monoclonal antibodies, antibody identification and screening panels, quality control kits,...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,815 delivery order to Alba Bioscience, Inc. on March 30, 2026, for ALBACLONE Anti-M immunohematology reagents, with completion scheduled for April 2, 2026. Place of performance is Chicago, IL. Alba Bioscience specializes in in vitro diagnostic products and blood banking materials, supplying monoclonal antibodies, antibody identification and screening panels, quality control kits, and additive solutions to federal healthcare systems....
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,750 delivery order to Alba Bioscience, Inc. on March 12, 2026, for ALBACLONE Anti-C monoclonal antibody reagent, with completion by March 17, 2026. Place of performance is Chicago, IL. Alba Bioscience supplies immunohematology reagents and blood banking diagnostic materials to federal healthcare systems, including monoclonal antibodies, antibody identification and screening panels, quality control kits, and specialized cell...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- <p>The Defense Logistics Agency Medical Supply Chain issued a $9,280 delivery order to Alba Bioscience, Inc. on April 30, 2026, for anti-IgG, C3D polyspecific (green) immunohematology reagents, with completion by May 5, 2026.</p> <p>Place of performance is Chicago, IL. The order is priced firm fixed price with no set-aside applied.</p>
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,150 to Alba Bioscience, Inc. for ALBACYTE Antibody Screen (2-Cell) products, with an ultimate completion date of October 9, 2025. Alba Bioscience, a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was selected through a non-set-aside competitive process. The delivery order falls under the company's existing blanket purchase agreements with the Department of Veterans Affairs, which...
- SPE2DE22D0008Indefinite Delivery Contract
- SPE2DE22D0008-SPE2D626F4J6FDelivery Order
The Defense Logistics Agency's Medical Supply Chain issued a $4,640 delivery order to Alba Bioscience, Inc. on April 30, 2026, for Albacyte antibody screen (2-cell) reagent supply, with completion by July 7, 2026. Place of performance is Chicago, IL. The order is firm fixed price with no set-aside applied.
Generated 7/29/26, 10:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/29/26 |